The Baylor College of Medicine Human Genome Sequencing Center (HGSC) is expanding its fleet of next-generation sequencing technology from Applied Biosystems. Additional SOLiD™ Systems will be integrated into the HGSC’s existing base of genomic analysis technologies. With a total of 20 systems, HGSC scientists will use these sequencing platforms to further conduct comprehensive analyses of the genetic changes that characterize cancer, autism, and cardiovascular diseases.
The HGSC research developments coincide with the NIH’s Gene Sequencing Programs including increased support for determination of genetic changes in each of the three disease areas. With the additional genomic analysis platforms and the increased throughput available from each system, the HGSC expects to at least triple its current sequence production.